In the intricate world of pharmaceutical chemistry, specific intermediates play pivotal roles in the synthesis of life-saving medications. Ethyl 3,4-Dihydroxybenzoate, identified by CAS number 3943-89-3, is one such compound, widely recognized for its significance as a pharmaceutical intermediate. This article delves into its chemical characteristics, applications, and the importance of sourcing it from reputable manufacturers.

Ethyl 3,4-Dihydroxybenzoate is a chemical compound with the molecular formula C9H10O4 and a molecular weight of approximately 182.17300 g/mol. Its synonyms include Ethyl Protocatechuate and 3,4-Dihydroxybenzoic Acid Ethyl Ester. Typically appearing as a white crystalline powder, it possesses properties like a melting point of 132-134 °C and a purity often specified at 99% or higher. These attributes make it a sought-after raw material for advanced chemical synthesis, especially within the pharmaceutical sector. For companies looking to purchase this compound, understanding these specifications is crucial.

The primary value proposition of Ethyl 3,4-Dihydroxybenzoate lies in its application as a key intermediate in the synthesis of Erlotinib and Erlotinib Hydrochloride. These drugs are critical in targeted cancer therapies, making the consistent and high-quality supply of their intermediates a priority. Procurement managers and R&D scientists often seek a dependable 'pharmaceutical intermediate supplier' that can guarantee batch-to-batch consistency and adherence to stringent quality standards. When you are looking to buy this intermediate, examining the supplier's credentials and product documentation is vital.

As a 'manufacturer of pharmaceutical intermediates in China', we understand the importance of reliable sourcing. The 'price of Ethyl 3,4-Dihydroxybenzoate' can vary based on purity, volume, and supplier. However, the focus should always remain on obtaining a product that meets the required specifications for your synthesis. Engaging with suppliers who can provide detailed technical data, such as physical and chemical properties, and support your regulatory filing processes is a significant advantage.

For those requiring this compound for research purposes or commercial production, identifying a trusted 'CAS 3943-89-3 manufacturer' is the first step. Companies often look for suppliers that offer a comprehensive product portfolio, including related impurities or custom synthesis options. Building a strong relationship with a chemical supplier that prioritizes quality, timely delivery, and clear communication ensures that your manufacturing processes remain efficient and compliant.

In conclusion, Ethyl 3,4-Dihydroxybenzoate is an indispensable intermediate for critical pharmaceutical applications like Erlotinib synthesis. By focusing on purity, reliability, and partnering with reputable manufacturers and suppliers, pharmaceutical companies can ensure the quality and efficacy of their end products. We encourage you to explore sourcing options for this vital compound to support your ongoing pharmaceutical development and production needs.